Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group

J Breuil1, A Dublanchet, N Truffaut

  • 1Laboratoire de Microbiologie, Centre Hospitalier, Villeneuve Saint Georges, France.

Plasmid
|March 1, 1989
PubMed

Insights

A specific strain of Bacteroides vulgatus (BV17) shows moderate resistance to 5-nitroimidazoles. This resistance is linked to a 7.7 kb plasmid (pIP417), transferable to other bacteria.

Area of Science:

  • Microbiology
  • Genetics
  • Antimicrobial Resistance

Background:

  • Bacteroides vulgatus is a common gut bacterium.
  • 5-nitroimidazoles are crucial antibiotics.
  • Antibiotic resistance in bacteria is a growing public health concern.

Purpose of the Study:

  • To characterize a strain of Bacteroides vulgatus (BV17) exhibiting 5-nitroimidazole resistance.
  • To identify the genetic elements responsible for this resistance.

Main Methods:

  • Plasmid profiling of B. vulgatus BV17.
  • Transformation and conjugation experiments to transfer plasmids.
  • Replication studies in sensitive bacterial strains.

Main Results:

  • B. vulgatus BV17 carries plasmids of 4.5, 5, 7.7, and 56 kb.
  • A 7.7 kb plasmid (pIP417) harbors the genetic determinant for 5-nitroimidazole resistance.
  • pIP417 can be transferred and replicated in B. fragilis 638R via transformation and conjugation.
  • Conjugal transfer may be facilitated by a 56 kb conjugative plasmid (pIP418).

Conclusions:

  • A novel plasmid-mediated resistance mechanism to 5-nitroimidazoles in Bacteroides vulgatus has been identified.
  • The 7.7 kb plasmid pIP417 is central to this resistance.
  • Understanding these mechanisms is vital for combating antimicrobial resistance.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Conjugation01:19

Conjugation

Conjugation is a form of horizontal gene transfer that primarily occurs in bacteria and some archaea, promoting genetic diversity and adaptation. Bacteria can acquire resistance genes through conjugative plasmids, allowing them to survive antibiotic treatments that would otherwise be lethal. This process involves direct contact between cells through specialized structures such as the sex pilus and is mediated by conjugative plasmids, including the F (fertility) factor.Conjugation requires...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Phylum Bacteroidota01:26

Bacterial Phylum Bacteroidota

The phylum Bacteroidota includes over 700 species classified into four primary orders: Bacteroidales, Cytophagales, Flavobacteriales, and Sphingobacteriales. These gram-negative, non-sporulating rods exhibit saccharolytic capabilities and can be aerobic or fermentative, encompassing obligate aerobes, facultative aerobes, and obligate anaerobes. Many species display gliding motility, though some are nonmotile or use flagella. The genus Bacteroides is well-studied due to its significant role in...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...